Eid Hoda M, Thong Farah, Nachar Abir, Haddad Pierre S
a Natural Health Products and Metabolic Diseases Laboratory, Department of Pharmacology and Physiology , Université de Montréal , Montreal , Canada.
b Canadian Institutes of Health Research Team in Aboriginal Antidiabetic Medicines, Montreal Diabetes Research Center , Montreal , Canada.
Pharm Biol. 2017 Dec;55(1):2026-2034. doi: 10.1080/13880209.2017.1345952.
Caffeic acid methyl (CAME) and ethyl (CAEE) esters stimulate glucose uptake and AMP-activated protein kinase (AMPK) in C2C12 myocytes (ATCC CRL-1772).
Effects of CAME and CAEE were now assessed on myocyte glucose transporter GLUT4 activity and expression, on hepatic gluconeogenesis and on adipogenesis as well as major underlying signaling pathways.
GLUT4 protein translocation was studied in L6 GLUT4myc cells, glucose-6-phospatase (G6Pase) in H4IIE hepatocytes and adipogenesis in 3T3-L1 adipocytes. Key modulators were measured using western immunoblot. Cells were treated for 18 h with either CAME or CAEE at various concentrations (12.5-100 μM).
Myocyte glucose uptake rose from 10.1 ± 0.5 to 18.7 ± 0.8 and 21.9 ± 1.0 pmol/min/mg protein in DMSO-, CAME- and CAEE-stimulated cells, respectively, similar to insulin (17.7 ± 1.2 pmol/min/mg protein), while GLUT4myc translocation increased significantly by 1.70 ± 0.18, by 1.73 ± 0.18- and by 1.95 ± 0.30-fold (relative to DMSO), following insulin, CAME and CAEE stimulation, respectively. CAME and CAEE suppressed hepatocyte G6Pase by 62.0 ± 6.9% and 62.7 ± 6.0% with IC of 45.93 and 22.64 μM, respectively, comparable to insulin (70.7 ± 2.3% inhibition). Finally, CAME and CAEE almost abrogated adipogenesis (83.3 ± 7.2% and 97.3 ± 3.0% at 100 μM; IC of 13.8 and 12.9 μM, respectively). The compounds inhibited adipogenic factors C/EBP-β and PPAR-γ and stimulated AMPK activity in the three cell-lines.
CAME and CAEE exerted antidiabetic activities in insulin-responsive cells through insulin-independent mechanisms involving AMPK and adipogenic factors.
咖啡酸甲酯(CAME)和乙酯(CAEE)可刺激C2C12肌细胞(ATCC CRL - 1772)摄取葡萄糖并激活AMP活化蛋白激酶(AMPK)。
现评估CAME和CAEE对肌细胞葡萄糖转运蛋白GLUT4活性和表达、肝糖异生、脂肪生成以及主要潜在信号通路的影响。
在L6 GLUT4myc细胞中研究GLUT4蛋白易位,在H4IIE肝细胞中研究葡萄糖 - 6 - 磷酸酶(G6Pase),在3T3 - L1脂肪细胞中研究脂肪生成。使用蛋白质免疫印迹法检测关键调节因子。细胞分别用不同浓度(12.5 - 100μM)的CAME或CAEE处理18小时。
在二甲基亚砜(DMSO)、CAME和CAEE刺激的细胞中,肌细胞葡萄糖摄取量分别从10.1±0.5升至18.7±0.8和21.9±1.0 pmol/分钟/毫克蛋白,与胰岛素(17.7±1.2 pmol/分钟/毫克蛋白)相似;而在胰岛素、CAME和CAEE刺激后,GLUT4myc易位分别相对于DMSO显著增加1.70±0.18倍、1.73±0.18倍和1.95±0.30倍。CAME和CAEE分别将肝细胞G6Pase抑制62.0±6.9%和62.7±6.0%,IC50分别为45.93和22.64μM,与胰岛素(抑制70.7±2.3%)相当。最后,CAME和CAEE几乎完全抑制脂肪生成(100μM时分别为83.3±7.2%和97.3±3.0%;IC50分别为13.8和12.9μM)。这两种化合物在三种细胞系中均抑制脂肪生成因子C/EBP - β和PPAR - γ并激活AMPK活性。
CAME和CAEE通过涉及AMPK和脂肪生成因子的非胰岛素依赖机制在胰岛素反应性细胞中发挥抗糖尿病活性。